Yao Ming Kangde (02359) AH shares rose more than 5% in the short term. As of press release, H shares rose 5.03% to HK$34.45, with a turnover of HK$143 million.
The Zhitong Finance App learned that Yao Ming Kangde (02359) AH shares rose by more than 5% in the short term. As of press release, H shares rose 5.03% to HK$34.45, with a turnover of HK$143 million.
According to the news, the latest information from the Stock Exchange shows that on April 11, J.P. Morgan Chase increased its holdings of Pharmaceutical Kangde H shares by 559,300 thousand shares with an average price of HK$35.4316 per share on the market and an average price of HK$35.4,605 per share outside the market, with a total price of HK$35.4,605 per share outside the market, to a total of 559,300 HKD shares. After increasing its holdings, J.P. Morgan Chase's latest shareholding ratio increased from 8.92% to 9.06%.
Changjiang Securities said that looking ahead to 2024, regular revenue is expected to maintain positive growth. Despite the uncertainty of the external environment, the company expects revenue to reach 383-40.5 billion in 2024, and will maintain positive growth after excluding COVID-19 commercialization projects (2.7-8.6%). After considering the rise in new production capacity and the impact of exchange rates, it is expected that 2024 will maintain an adjusted non-IFRS net interest rate similar to last year.